SCHEMBL273608

SCHEMBL273608

CCC1(C(=O)O)OC1c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
KMT2A Q03164 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MAPT P10636 1/20 0.38
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
KDM1A O60341 6/20 0.36
MAOA P21397 6/20 0.36
MAOB P27338 6/20 0.36
POLB P06746 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
HCAR3 P49019 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884144 1.00 TSHR (0.39) TSHRKMT2ANPSR1MAPTGAA
SCHEMBL8876521 1.00 TSHR (0.39) TSHRKMT2ANPSR1MAPTGAA
SCHEMBL4888244 0.86 KDM1A (0.38) TSHRKMT2ANPSR1MAPTGAA
SCHEMBL15659315 0.86 TSHR (0.37) TSHRKMT2ANPSR1MAPTGAA
SCHEMBL17294064 0.84 HDAC4 (0.40) KMT2AMAPTGAAKDM4EALDH1A1
SCHEMBL14968287 0.83 MAPT (0.41) TSHRKMT2ANPSR1MAPTALDH1A1
SCHEMBL9355549 0.82 ALDH1A1 (0.43) TSHRKMT2AGAAKDM4EALDH1A1
SCHEMBL14967143 0.82 TSHR (0.48) TSHRKMT2AGAAKDM4EALDH1A1
SCHEMBL9355324 0.82 ALDH1A1 (0.43) TSHRKMT2AGAAKDM4EALDH1A1
SCHEMBL14967898 0.81 MAPT (0.39) TSHRKMT2ANPSR1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10876081-B2 Method for the production of scent capsules with improved surfactant stability SYMRISE AG (DE) 2020-12-29 US claimed
EP-3423028-B1 METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS SYMRISE AG (DE) 2020-04-08 EP claimed
WO-2020015880-A1 BI-PHASE DEODORIZING COSMETIC COMPOSITION BEIERSDORF AG (DE) 2020-01-23 WO claimed
EP-3006547-B1 FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED SHISEIDO CO LTD (JP) 2019-10-30 EP claimed
EP-3423028-A1 METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY Symrise AG (DE) 2019-01-09 EP claimed
EP-2780177-B1 METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW BRIDGESTONE CORP (JP) 2016-03-23 EP claimed
EP-2110118-B1 Malodour reducing composition and uses thereof TAKASAGO PERFUMERY CO LTD (JP) 2014-11-19 EP claimed
WO-2011147455-A1 FLAVORING SUBSTANCE-INCLUDED COMPOUNDS SYMRISE AG (DE) 2011-12-01 WO claimed
EP-2076555-B1 METAL COORDINATING AND FILM-FORMING MATERIALS BASF CORP (US) 2011-01-05 EP claimed
EP-2110118-A1 Malodour reducing composition and uses thereof Takasago International Corporation (JP) 2009-10-21 EP claimed
EP-2076555-A1 METAL COORDINATING AND FILM-FORMING MATERIALS BASF Corporation (US) 2009-07-08 EP claimed
EP-1565074-B1 FLAVOUR COMPOSITIONS QUEST INT SERV BV (NL) 2008-05-07 EP claimed
WO-2008051648-A1 METAL COORDINATING AND FILM-FORMING MATERIALS BASF CORPORATION (US) 2008-05-02 WO claimed
US-20080103268-A1 Substrate adhesion, reduced cure temperatures, simple production; electrocoatings BASF CORPORATION (US) 2008-05-01 US claimed
EP-0612826-B1 Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processing for making such solid films and devices DONNELLY CORP (US) 2000-10-04 EP claimed
EP-4214211-B1 SECO-AMBRAKETALS SYMRISE AG (DE) 2024-07-10 EP disclosed
EP-4393581-A2 BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES Symrise AG (DE) 2024-07-03 EP disclosed
EP-0643626-A4 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL. RES CORP TECHNOLOGIES INC (US) 1995-12-06 EP disclosed
EP-0643626-A1 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-03-22 EP disclosed
WO-1993003838-A1 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10876081-B2 Method for the production of scent capsules with improved surfactant stability SMOX, LIPA, SGMS2 TSHR 4699/4885KMT2A 1413/4885NPSR1 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.